cardiomyopathy and heart failure; however, emerging consensus points to paracrine mechanisms with rapid loss of the delivered cells within hours after administration, precluding a sustainable therapeutic effect (1) . A major breakthrough toward this goal has been the observation that existing mammalian cardiac myocytes divide at a low rate of 0.5% to 2.0% per year in humans (2) and rodents (3) throughout life. However, cardiac myocyte division is only modestly stimulated after injury (as in the border zone of an MI [3] ), and there is no discernible contribution from resident or recruited progenitor cells to cardiac myocyte regeneration, underscoring the insufficiency of endogenous mechanisms for replacement of functional myocardium (reviewed elsewhere [1] ).
In contrast to the adult mammalian heart, in 1-dayold mouse pups, a robust regenerative response is seen in the immediate post-natal period driven by cell 
